Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Boldt A et al. |
The influence of immunosuppressive drugs on T- and B-cell apoptosis via p53-mediated pathway in vitro and in vivo. |
2006 |
Transplantation |
pmid:16906043
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Gonwa TA et al. |
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. |
2001 |
Transplantation |
pmid:11773892
|
Fisher RA et al. |
A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9884248
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Borrows R et al. |
Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16421488
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Shaffer D et al. |
Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). |
1995 |
Transplantation |
pmid:7535958
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Cantarovich D et al. |
Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. |
2005 |
Transplantation |
pmid:15714172
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Inamura N et al. |
Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. |
1988 |
Transplantation |
pmid:2447690
|
Kuypers DR et al. |
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. |
2013 |
Transplantation |
pmid:23263559
|
White M et al. |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. |
2006 |
Transplantation |
pmid:17006323
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|